IMCD NV/ NL0010801007 /
1/23/2025 5:35:18 PM | Chg. +0.25 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
145.95EUR | +0.17% | 89,990 Turnover: 13.15 mill. |
144.50Bid Size: 715 | 147.50Ask Size: 7 | 8.31 bill.EUR | 1.53% | 28.45 |
GlobeNewswire
3/2/2022
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Ac...
GlobeNewswire
2/16/2022
Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melano...
GlobeNewswire
3/18/2020
Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study
GlobeNewswire
1/13/2020
EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® ...
GlobeNewswire
2/28/2019
Adhesives - Global Market Analysis, Trends and Forecasts 2019: Outsourcing of Manufacturing Activity...
GlobeNewswire
11/16/2018
Asia Pacific Biopharma Excipients (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates, S...
GlobeNewswire
9/26/2018
IMCD completes acquisition of European speciality chemicals distributor Velox
GlobeNewswire
8/1/2018
IMCD completes acquisition of US specialty chemicals distributor E.T. Horn Company
GlobeNewswire
3/5/2018
Nutraceutical Excipients Market Poised to Register 7.3% CAGR through 2026, globally - Future Market ...
GlobeNewswire
3/2/2018
IMCD to nominate Management Board and Supervisory Board members for (re)appointment
GlobeNewswire
2/8/2018
Adhesives Markets 2016-2024 by Volume & Value - Global Strategic Business Report 2017